TIMM 4th (2012)

Title Content type
The clinically important black yeast, Exophiala jeanselmei and its in vitrosusceptibility to antifungal agents (click for details)
Antifungal activity of Isavuconazole and comparators against chromoblastomycotic Cladophialophora spp. (click for details)
Posaconazole has superior clinical efficacy and cost-effectiveness than itraconazole for antifungal prophylaxis in allogeneic stem cell transplant recipients: A single-centre experience (click for details)
In vitro minimum Inhibitory Concentration (MFC) of Myrtus Communis oils in Comparison to nystatin on clinical Isolates and standard strains of candida albicans (click for details)
Amphotericin B, voriconazole and caspofungin activity against Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic (PK/PD) diffusion system simulating human pharmacokinetics (click for details)
Characteristics of vulvovaginitis caused by Saccharomyces cerevisiae and antifungal susceptibility of clinical isolates (click for details)
Biofilm production by isolates of Candida species and by mixed Candida species recovered from 100 denture wearers (click for details)
Therapeutic drug monitoring of voriconazole in pediatric patients (click for details)
Cumulative Diagnostic Value of Galactomannan and Anti-Aspergillus Antibodies Detection in Children with Haematooncology Diseases (click for details)
Building work in a paediatric haematology/oncology unit: successful strategies to prevent invasive fungal infection in immunocompromised patients during construction of HEPA-filtered cubicles (click for details)


Subscribe to TIMM 4th (2012)